MRK

Merck & Co., Inc.

Healthcare
145.95 up +0.60 +0.41% Pre-Market
2026-10-16 • USD

Key Metrics

Market Cap 360.08B
EV 406.85B
Shares Out 2.47B
Revenue (ttm) 66.57B
Net Income 3.17B
Beta —
P/E —
Forward P/E —
EPS (ttm) $1.25
P/S 5.42
P/B 8.60
P/FCF 22.44
P/C 18.05
EV/Sales 6.11
EV/EBITDA —
ROA 2.45%
ROE 6.77%
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin 4.77%
Debt/Eq 1.29
LT Debt/Cap 54.92%
Quick Ratio 0.71
Current Ratio 1.32
Book/sh 16.98
Cash/sh 2.77
Div Yield 2.3%
Div TTM $3.36
Payout Ratio 268.8%
SMA20 0.14%
SMA50 0.57%
SMA200 16.88%
Volume 11,233,873
Avg Volume 10.30M
Rel Volume 1.09
Perf Week 0.34%
Perf Month -0.55%
Perf Quarter 14.47%
Perf Half Y 22.57%
Perf YTD 38.66%
Perf Year 72.13%
Perf 3Y 45.33%
Perf 5Y 83.61%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.8500
TTM Yield 2.30%
TTM Amount $3.36
Payout Ratio 268.8%
3-Yr Growth (CAGR) 5.42%
5-Yr Growth (CAGR) 5.75%

Last 12 Payouts

Period Ex-Date Amount / Share
Q2 2026 ~2026-06-30 $0.8500
Q1 2026 ~2026-03-31 $0.8500
Q4 2025 ~2025-12-30 $0.8500
Q3 2025 ~2025-09-30 $0.8100
Q2 2025 ~2025-06-30 $0.8100
Q1 2025 ~2025-03-31 $0.8100
Q4 2024 ~2024-12-30 $0.8100
Q3 2024 ~2024-09-30 $0.7700
Q2 2024 ~2024-06-30 $0.7700
Q1 2024 ~2024-03-31 $0.7700
Q4 2023 ~2023-12-30 $0.7700
Q3 2023 ~2023-09-30 $0.7300

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Merck & Co., Inc. is a leading global healthcare company engaged in the business of discovering, developing, producing and marketing a broad range of human and animal health…

Name
Merck & Co., Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert M. Davis · Chairman, Chief Executive Officer and President
Employees
—
IPO Date
2018-03-01
Phone
908-740-4000
Address
126 East Lincoln Avenue, Rahway, NJ 07065
Website
www.merck.com

Key Executives

Name Title FY Pay
Jennifer Zachary Executive Vice President and General Counsel —
Dean Li, M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories —
Sanat Chattopadhyay Executive Vice President and President, Merck Manufacturing Division —
Caroline Litchfield Executive Vice President and Chief Financial Officer —
Robert M. Davis Chairman, Chief Executive Officer and President —

Latest News